SPHK1 and pulmonary fibrosis: Furthermore, a murine model of bleomycin (BLM)-induced pulmonary fibrosis in Sphk1-deficient mice confirmed protection against PF, confirming the data from IPF patients depicting an enhanced SPHK1 and S1PL expression in lung tissues [26].